A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paula R Clemens, MD
University of Pittsburgh
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Children'S Hospital
Melbourne, Australia
- Sydney Children'S Hospital
Westmead, Australia
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- Schneider Children'S Medical Center
Petah Tikvah, Israel
- Queen Silvia Children'S Hospital
Gothenburg, Sweden
- Newcastle Upon Tyne Hospitals Nhs Foundation Trust
Newcastle upon Tyne, United Kingdom
- University of California Davis
Davis, California, United States
- University of Florida
Gainesville, Florida, United States
- Nemours Children'S Hospital
Orlando, Florida, United States
- Ann & Robert H. Lurie Children'S Hospital
Chicago, Illinois, United States
- Duke University
Durham, North Carolina, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2016
- Primary completion
- 1 May 2018
- Completion
- 1 May 2018
- Last update posted
- 2 Jan 2019
- Registered enrollment
- 48
- Registry id
- NCT02760264
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.